This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ford, B. M. Articles by Syngal, S. Search for Related Content PubMed PubMed Citation Articles by Ford, B. M. Articles by Syngal, S.

Factors Associated with Enrollment in Cancer Genetics Research

Divisions of ¹ Population Sciences and ² Biostatistics, Dana-Farber Cancer Institute; ³ Division of Gastroenterology, Brigham and Women's Hospital; ⁴ Department of Medicine, Mount Auburn Hospital; ⁵ Harvard Medical School, Boston, Massachusetts; and ⁶ Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain

Requests for reprints: Sapna Syngal, Dana-Farber Cancer Institute 1 Jimmy Fund Way, SM 209 Boston, MA 02115. Phone: 617-632-5022; Fax: 617-632-4088. E-mail: ssyngal{at}partners.org

Previous studies have identified low patient accrual in large-scale cancer clinical trials, particularly for underrepresented groups, such as ethnic minorities, females, and patients >65 years. As there have been few studies examining participation in cancer genetics epidemiologic research, our objective was to identify clinical and demographic factors predicting enrollment in these studies. A total of 1,111 patients diagnosed with colorectal cancer presenting to a gastrointestinal oncology clinic were approached to enroll in a study investigating the role of the MSH6 gene in familial colorectal cancer. Patient consent was sought for providing a blood specimen for DNA analysis and review of medical records/tumor specimens and contacting family members to confirm the family history of cancer. Seven predictor variables for enrollment (age, sex, ethnicity, family history of colorectal cancer in a first-degree relative, presence of children, insurance type, and type of visit) were analyzed using logistic regression analysis to determine the effect on decision to enroll. Of 1,111 patients approached, 696 (62.6%) enrolled in the study. Of these approached individuals, 4.2% were of nonwhite ethnicity and 33.5% were age 65 years. Patients of white ethnicity [odds ratio (OR), 2.10; P = 0.018], males (OR, 1.47; P = 0.002), those ages 65 years (OR, 1.42; P = 0.009), and those with a first-degree relative with colorectal cancer (OR, 1.57; P = 0.005) were significantly more likely to enroll. Fewer than 4% of all participants denied permission for the study researchers to access information from medical records or to be recontacted by researchers to discuss the enrollment of additional family members. Our data suggest that, once subjects decided to enroll, the majority (88%) was comfortable with consenting to all study components, including the creation of cell lines and future recontact. Low participation rates for ethnic minorities, females, and elderly patients are similar for both cancer genetics and clinical trial studies. (Cancer Epidemiol Biomarkers Prev 2006;15(7):1355–9)

This article has been cited by other articles:

				T. M. Pawlik, D. Laheru, R. H. Hruban, J. Coleman, C. L. Wolfgang, K. Campbell, S. Ali, E. K. Fishman, R. D. Schulick, J. M. Herman, et al. Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2081 - 2088. [Abstract] [Full Text] [PDF]

				K. D. Graves, L. M. Moss, C. L. Jasper, T. A. DeMarco, B. N. Peshkin, C. Isaacs, and M. D. Schwartz Predictors of Enrollment into a Familial Cancer Registry by Individuals at High Risk for BRCA1/2 Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2763 - 2767. [Abstract] [Full Text] [PDF]

				S. W. Gray, F. J. Hlubocky, M. J. Ratain, and C. K. Daugherty Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials J. Clin. Oncol., August 10, 2007; 25(23): 3488 - 3494. [Abstract] [Full Text] [PDF]

				E. L. Ding, N. R. Powe, J. E. Manson, N. S. Sherber, and J. B. Braunstein Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical Trials: A Randomized Study of Cardiovascular Prevention Trials Arch Intern Med, May 14, 2007; 167(9): 905 - 912. [Abstract] [Full Text] [PDF]